Navidea Announces Presentation of Study Findings of Manocept™ Platform Imaging Agent in Kaposi Sarcoma at AACR Annual Meeting Apr 10, 2014
Navidea Announces Presentations Highlighting NAV4694 Beta-Amyloid, PET Imaging Agent at the German Society of Nuclear Medicine Congress Mar 26, 2014
Navidea Biopharmaceuticals Provides Update on European Marketing Authorization Application for Lymphoseek® Mar 19, 2014
Navidea Biopharmaceuticals Announces Presentation of Lymphoseek® Three-Year Recurrence and Survival Outcomes after Sentinel Lymph Node Biopsy in Patients with Breast Cancer and Melanoma Mar 14, 2014
Navidea Announces Acceptance for Review of an Additional sNDA to Further Expand Lymphoseek® Labeling Mar 5, 2014
Navidea Biopharmaceuticals to Announce Fourth Quarter and Full-Year 2013 Financial Results on Thursday, March 6, 2014 Mar 3, 2014
